info iconCurrently, the share price for Glenmark Pharmaceuticals Ltd. is delayed.

close icon
Glenmark Pharmaceuticals Ltd. Logo

Glenmark Pharmaceuticals Ltd.

₹894.15
NSE
--   ( -- %) 1D



  • Prev. Close
    894.15
  • Upper Circuit
    983.55
  • Lower Circuit
    804.75

Analyst Recommendations For Glenmark Pharmaceuticals Ltd.

Info icon
As recommended by 6 analysts

Returns

Glenmark Pharmaceuticals Ltd.'s Info & Management

Glenmark Pharmaceuticals is primarily engaged in the business of development, manufacture and marketing of pharmaceutical products.
  • Executive Director,Global Chief Financial Officer
    V S Mani
  • Executive Director(Corporate Services)
    Cheryl Pinto
  • Company Secretary,Compliance Officer
    Harish Kuber

FAQs on Glenmark Pharmaceuticals Ltd.

What is the share price of Glenmark Pharmaceuticals Ltd.?

Glenmark Pharmaceuticals Ltd. share price is ₹900.60 as of February 21, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Glenmark Pharmaceuticals Ltd.?

The 52-week high and low of Glenmark Pharmaceuticals Ltd. is ₹922.70 and ₹414.25 respectively as of February 21, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Glenmark Pharmaceuticals Ltd.?

The trailing twelve month (TTM) PB ratio of Glenmark Pharmaceuticals Ltd. is 2.50 as of February 21, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Glenmark Pharmaceuticals Ltd.?

The Upper Circuit of Glenmark Pharmaceuticals Ltd. is ₹984. The Lower Circuit of Glenmark Pharmaceuticals Ltd. is ₹805.

What is the ROE of Glenmark Pharmaceuticals Ltd.?

Glenmark Pharmaceuticals Ltd. reported an ROE of 3.13% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Glenmark Pharmaceuticals Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Glenmark Pharmaceuticals Ltd., Promoter held 46.6%, the FII held 23.7%, DII held 11% and the public held 18.7% of the total shares.

How to buy Glenmark Pharmaceuticals Ltd. Share?

You can easily buy shares of Glenmark Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Glenmark Pharmaceuticals Ltd.?

The fair value of Glenmark Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer